The Alzheimer’s Network for Treatment and Diagnostics is a platform for patients, families and caregivers to access resources about Alzheimer’s disease, including links to medical experts, opportunities to participate in research, and cutting-edge news.
ALZ-NET collects data from individuals who are being evaluated for or are receiving treatment with novel FDA-approved therapies for Alzheimer’s disease. Novel FDA-approved therapies for AD are drugs that have received approval as treatments for Alzheimer's disease (AD) from the U.S. Food and Drug Administration since 2021. ALZ-NET will track clinical, safety and long-term health outcomes of individuals in real-world settings from a variety of backgrounds and communities. This network is sponsored by the Alzheimer’s Association and managed by the American College of Radiology.
With patients’ willingness to provide data on their Alzheimer's disease treatment and care, ALZ-NET researchers can learn about real world patterns in diagnosing and treating Alzheimer’s disease. By understanding patterns in care today, ALZ-NET can help health practitioners treat Alzheimer’s Disease in the future. ALZ-NET aims to be a resource for evidence gathering, information sharing, and education across clinical and research communities to support and improve care of individuals living with Alzheimer’s disease.
ALZ-NET does not require any additional effort on a participant’s behalf other than routinely visiting your health practitioner.
Your health practitioner will advise if you are eligible to participate in ALZ-NET. Your health practitioner needs to be an active enrolled site in ALZ-NET. If they are not actively participating in ALZ-NET, you can search our directory for a provider that is.
Browse our list of approved organizations and doctors to find Alzheimer’s care in your area by medical professionals that are participating in ALZ-NET. This listing is updated frequently as new sites join ALZ-NET.
ALZ-NET does not require any additional procedures to be completed outside of the care a patient would otherwise receive.
Participants will visit their memory care provider as they normally would without participating in ALZ-NET.
Once registered, participation in ALZ-NET continues for as long as consent is provided and care is being received by the memory care provider.
Patients will not receive any compensation for participating in ALZ-NET.
All care that is provided will be charged to the patient’s health insurance provider. Standard co-payments will remain the patient’s responsibility, as they would without participating in ALZ-NET.
Medications administered to patients is done so as part of their care plan, not as part of participating in ALZ-NET.